VIA
CDMO

Virtus Investment Advisers’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Virtus Investment Advisers’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-21,827
Closed -$206K – 382
2023
Q3 		$206K Sell
21,827
-38,642
-64% -$465K 0.14% 172
2023
Q2 		$845K Hold
60,469
– – 0.57% 40
2023
Q1 		$1.13M Sell
60,469
-3,851
-6% -$63.3K 0.79% 29
2022
Q4 		$886K Hold
64,320
– – 0.59% 41
2022
Q3 		$1.23M Buy
+64,320
New +$1.17M 0.57% 24

Other funds holding CDMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Virtus Investment Advisers's CDMO Position: Q4 2023 in Review

Virtus Investment Advisers sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2023, closing a stake of 21,827 shares — an estimated $206K sold.

Virtus Investment Advisers first reported a position in CDMO in Q3 2022 and held it in 5 quarters. The position peaked at $1.23M in Q3 2022. 174 funds tracked by Wall St. Rank hold CDMO as of Q4 2023.

  • Virtus Investment Advisers reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Virtus Investment Advisers sold 21,827 Avid Bioservices, Inc. Common Stock shares in Q4 2023, an estimated $206K.
  • Virtus Investment Advisers first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • Virtus Investment Advisers's Avid Bioservices, Inc. Common Stock position peaked at $1.23M in Q3 2022.
  • 174 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2023.

Based on Virtus Investment Advisers's 13F filing for Q4 2023, filed 15 Feb 2024.